0000899243-20-035009.txt : 20201223 0000899243-20-035009.hdr.sgml : 20201223 20201223172635 ACCESSION NUMBER: 0000899243-20-035009 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201222 FILED AS OF DATE: 20201223 DATE AS OF CHANGE: 20201223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hofmeister Robert CENTRAL INDEX KEY: 0001760102 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38811 FILM NUMBER: 201413649 MAIL ADDRESS: STREET 1: C/O TCR2 THERAPEUTICS INC. STREET 2: 100 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TCR2 THERAPEUTICS INC. CENTRAL INDEX KEY: 0001750019 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 474152751 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-949-5200 MAIL ADDRESS: STREET 1: 100 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-12-22 0 0001750019 TCR2 THERAPEUTICS INC. TCRR 0001760102 Hofmeister Robert TCR2 THERAPEUTICS INC. 100 BINNEY STREET CAMBRIDGE MA 02142 0 1 0 0 Chief Scientific Officer Common Stock 2020-12-22 4 M 0 7000 0.74 A 45850 D Stock Option (Right to Buy) 0.74 2020-12-22 4 M 0 7000 0.00 D 2026-12-13 Common Stock 7000 28732 D The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. 25% of this option shall vest and become exercisable on December 13, 2017, with the remainder vesting in thirty-six (36) equal monthly installments thereafter. /s/ Margaret Siegel as Attorney-in-Fact 2020-12-23